Internal Medicine, Infectious Disease · El Paso, TX
NPI
1760433924
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
12800 Edgemere Blvd, Suite A
El Paso, TX, 79924
Phone (915) 504-6939
Groups this clinician bills Medicare through
Medicare paid, 2024
$309K
4,189 services
Medicare patients, 2024
524
Average age 74
Drug cost, 2024
$163K
1,240 prescriptions
Company payments, 2025
$129
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Richard E Pieri was code 99232 (hospital e&m - subsequent), 2,060 times for 441 patients. In total Richard E Pieri billed 4,189 services in 10 codes, and Medicare paid $309K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-12-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 2,060 | 441 | $54.41 | $112K |
| 99233 Hospital E&M - Subsequent | Facility | 1,337 | 392 | $81.95 | $110K |
| 99223 Hospital E&M - Initial | Facility | 613 | 468 | $119.11 | $73K |
| 99213 Office E&M - Established | Office | 63 | 31 | $58.45 | $3,683 |
| 99212 Office E&M - Established | Office | 53 | 44 | $35.41 | $1,877 |
By year: 2022 $307K for 3,955 services; 2023 $332K for 4,145 services; 2024 $309K for 4,189 services.
Medicare prescription drug claims, 2024
In 2024, the drug Richard E Pieri prescribed most often to Medicare patients was Ceftriaxone (Ceftriaxone Sodium), with 152 prescriptions and refills. In total Richard E Pieri wrote 1,240 Medicare prescriptions that cost $163K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ceftriaxone Ceftriaxone Sodium | 152 | 152 | 45 | $7,265 |
| Daptomycin Generic | 137 | 137 | 39 | $33K |
| Cefepime Hcl Generic | 116 | 116 | 30 | $26K |
| Vancomycin Hcl Generic | 109 | 109 | 27 | $14K |
| Meropenem Generic | 84 | 84 | 34 | $23K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 73 | 73 | 24 | $842 |
| Ertapenem Ertapenem Sodium | 67 | 67 | 26 | $20K |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 63 | 63 | 39 | $1,036 |
| Sodium Chloride 0.9 % Sodium Chloride | 59 | 59 | 20 | $1,423 |
| Cephalexin Generic | 50 | 50 | 20 | $761 |
| Cefazolin Sodium Generic | 38 | 38 | Under 11 | $2,659 |
| Ciprofloxacin Hcl Generic | 34 | 40 | 13 | $662 |
| Doxycycline Hyclate Generic | 29 | 35 | Under 11 | $584 |
| Fluconazole Generic | 27 | 41 | Under 11 | $1,477 |
| Levofloxacin Generic | 22 | 22 | 13 | $95.19 |
Brand drugs: 74 claims; generic drugs: 1,166 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Richard E Pieri $129 ($129 in general payments such as food, travel and fees) from 1 company. The largest payer was AngioDynamics, Inc. with $129.
| Company | Payments | Amount |
|---|---|---|
| AngioDynamics, Inc. ANGO | 1 | $129 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.